Integrated drug discovery panel – your questions answered!
Supported by:
7 November 2017
ABOUT THIS WEBINAR
Drug Discovery from concept to drug candidate has become a collective effort where multi-disciplinary project teams from CRO’s work with drug companies and academia to deliver clinical candidates, overcoming multi-factorial research obstacles along the way.
Charles River has established an Integrated Drug Discovery team of experts with diverse backgrounds across multiple therapeutic areas whose sole purpose is to innovate, consult, and proactively solve problems on your discovery programs.
During this peer panel discussion, team members from Charles River discussed their views and strategies on Drug Discovery and gave their answers to your challenging questions.
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Drug Discovery, Drug Discovery Processes, In Vitro, In Vivo, Oncology, Research & Development, Target Validation, Therapeutics
Related organisations
Charles River Laboratories
